Cargando…
Defining the Optimal Management Strategy for Small Renal Masses
Autores principales: | Dall’Era, Marc, Lara, Primo N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474519/ https://www.ncbi.nlm.nih.gov/pubmed/34632170 http://dx.doi.org/10.3233/KCA-200008 |
Ejemplares similares
-
Active Surveillance for Localized Prostate Cancer – Current Practices and Recommendations
por: Wu, Jennifer N., et al.
Publicado: (2010) -
Evaluating the Optimal Duration of Immunotherapy in Kidney Cancer
por: Parikh, Mamta, et al.
Publicado: (2022) -
Indications for and transitioning to secondary treatment while on active surveillance for prostate cancer
por: Glass, Allison S., et al.
Publicado: (2018) -
Active Surveillance for Intermediate Risk Prostate Cancer
por: Dall'Era, Marc A., et al.
Publicado: (2016) -
Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome
por: Dall'Era, Maria, et al.
Publicado: (2015)